Thyroid nodule historical perspective: Difference between revisions
| Line 8: | Line 8: | ||
In 2700 BC, seaweed were used for the treatment of goiter. | In 2700 BC, seaweed were used for the treatment of goiter. | ||
40 BC Pliny, Vitruvius, and Juvenal | In 40 BC, Pliny, Vitruvius, and Juvenal were the first who documented the prevalence of goiter in the Alps. They also used the burnt seaweed for treatment of goiter. | ||
138 | In 138, Soranus, a Greek physician, reported a case of neck swelling following pregnancy | ||
340 | In 340, Ko-Hung, a chinese alchemist recommended seaweed for treatment of goiter among people living in mountains. | ||
650 | In 650, Sun Ssu-Mo, another chinese physician, used dried, powdered mollusca shells and chopped thyroid gland for the treatment of goiter | ||
961 | In 961, Abul Kasim, a physician in Codoba, was the first who described thyroidectomy and to perform a needle biopsy | ||
1200 | In 1200, Arnaldus de Villanova reported that marine sponges could be used to treat goiters. | ||
1475 | In 1475, Wang Hei, a chinese physician recommended treat of goiter with minced thyroid | ||
1500 | In 1500, Leonardo da Vinci was the first who recognized and drew the thyroid gland | ||
1543 | In 1543, Andreas Vesalius was the first who provided the first anatomic description and illustration of the thyroid gland. | ||
1563 | In 1563, Eustachius was the first who introduced the term "isthmus" to describe tissue connecting the two lobes of the thyroid | ||
1602 Felix Platter was the first who described cretins found in Valais region of switzerland | In 1602, Felix Platter was the first who described cretins found in Valais region of switzerland | ||
In 1825, C. Parry was the first who described exophthalmic goiter. | |||
In 1834, Robert Graves was the first who described described a syndrome of palpitation, goiter, and exophthalmos and called the disease as Grave's disease | |||
In 1857, B. Niepce was the first who described enlargement of sella turcica in cretins with hypothyroidism in Switzerland. | |||
In 1857, B. | |||
In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals. | In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals. | ||
| Line 104: | Line 98: | ||
In 1998, United States scientists was the first country that approved clinical usage of recombinant human TSH. | In 1998, United States scientists was the first country that approved clinical usage of recombinant human TSH. | ||
== Landmark events == | |||
* In 1831, Iodine prophylaxis propsed as a goverment-administered public health program, for goiter prevention. | |||
==References== | ==References== | ||
Revision as of 20:21, 23 August 2017
|
Thyroid nodule Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thyroid nodule historical perspective On the Web |
|
American Roentgen Ray Society Images of Thyroid nodule historical perspective |
|
Risk calculators and risk factors for Thyroid nodule historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
Historical perspective
In 2700 BC, seaweed were used for the treatment of goiter.
In 40 BC, Pliny, Vitruvius, and Juvenal were the first who documented the prevalence of goiter in the Alps. They also used the burnt seaweed for treatment of goiter.
In 138, Soranus, a Greek physician, reported a case of neck swelling following pregnancy
In 340, Ko-Hung, a chinese alchemist recommended seaweed for treatment of goiter among people living in mountains.
In 650, Sun Ssu-Mo, another chinese physician, used dried, powdered mollusca shells and chopped thyroid gland for the treatment of goiter
In 961, Abul Kasim, a physician in Codoba, was the first who described thyroidectomy and to perform a needle biopsy
In 1200, Arnaldus de Villanova reported that marine sponges could be used to treat goiters.
In 1475, Wang Hei, a chinese physician recommended treat of goiter with minced thyroid
In 1500, Leonardo da Vinci was the first who recognized and drew the thyroid gland
In 1543, Andreas Vesalius was the first who provided the first anatomic description and illustration of the thyroid gland.
In 1563, Eustachius was the first who introduced the term "isthmus" to describe tissue connecting the two lobes of the thyroid
In 1602, Felix Platter was the first who described cretins found in Valais region of switzerland
In 1825, C. Parry was the first who described exophthalmic goiter.
In 1834, Robert Graves was the first who described described a syndrome of palpitation, goiter, and exophthalmos and called the disease as Grave's disease
In 1857, B. Niepce was the first who described enlargement of sella turcica in cretins with hypothyroidism in Switzerland.
In 1857, Maurice Schiff was the first to perform a successful total thyroidectomies in animals.
In 1862, A. Trousseau introduced the term "Graves disease" for the disease that was described before bby Grave.
In 1867, A. von Graefe described lid lag in thyrotoxicosis which later was known as Basedow's disease.
In 1873, Th. Billroth was the first to describe tetany following total thyroidectomy.
In 1882, William Ord was the first to describe the term myxedema for a case of a middle aged woman with cretinoid features.
In 1888, Rogowitsch was the first to describe the pituitary hyperplasia in rabbits following thyroidectomy.
In 1891, Victor Horsley was the first to discovered the direct effect of thyroid function deficiency in developing myxedema, cretinism, and post-thyroidecomy cachexia by working on monkeys.
In 1891, G. R. Murray was the first to describe the effect of thyroid extract in treating myxedema
In 1895, Adolf Magnus Levy was the first to describe the influence of the thyroid on the basal metabolic rate
In 1896, B. Riedel was the first to describe chronic fibrous thyroiditis.
In 1898, von Notthalt was the first to describe thyrotoxicosis factitia
In 1902, F. de Quervain was the first that described subacute granulomatous thyroiditis.
In 1905, Dr. Robert Abbe was the first who treated the graves disease by implanting radium into the patients goiter
In 1910, Charles H. Mayo was the first who described the term "hyperthyroidism" for explaining the clinical manifestations of primary exophthalmic goiter, toxic adenoma, and adenomatous goiter with hyperthyroidism.
In 1914, E. C. Kendall was the first who isolated thyroxine
In 1917, M. Seymour in Boston was the first who described the usage of X ray for treating Graves disease.
In 1924, H. S. Plummer at the Mayo clinic was the first who described the pre-operative usage of iodine for Graves disease treatment.
In 1928, Harington and Barger were the first who described the chemical structure of thyroxine and synthesize it.
In 1931, L. Loeb and R. Bassett were the first who extracted and purified TSH from bovine pituitaries.
In 1936, Dr. Saul Hertz was the first who described the usage of radioactive iodine for the study of the thyroid.
In 1946, A. Astwood was the first who used thiourea and thiouracil for medical treatment of graves disease.
In 1947, Cope, Rawson, and McArthur were the first who described the usage of radioactive iodine to demonstrate a "hot" thyroid nodule.
In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine needle thyroid biopsy as a diagnostic method for thyroid nodules.
In 1949, R. G. Hoskins was the first who described negative feedback of thyroid on pituitary, a mechanism that he called "servo (feedback) mechanism"
In 1949, Jones, Kornfeld, McLaughlin, and Anderson were the first who synthesize methimazole.
In 1950, J. B. Stanbury was the first who described the genetic abnormality association with thyroid hormone synthesis.
In 1959, J. B. Hazard, W. A. Hawk, and G. Crile were the first eho described medullary thyroid cancer as a distinct entity.
In 1965, S. Berson and R. Yalow were the first who described radioimmunoassay procedure.
In 1966, R. F. Rohner, J. T. Prior and J. H. Sipple were the first who described multiple endocrine neoplasia type 2 and reported some cases.
In 1970, A. Schally and R. Guillemin were the first who discovered TRH seperately from each other.
In 1998, United States scientists was the first country that approved clinical usage of recombinant human TSH.
Landmark events
- In 1831, Iodine prophylaxis propsed as a goverment-administered public health program, for goiter prevention.